Blood cancers, Myeloma
Results
Phase 3
This trial looked at an antibiotic called levofloxacin to see if it reduced the risk of infection and death in people starting treatment for myeloma.
Recruitment start: 15 August 2012
Recruitment end: 30 April 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mark Drayson
NIHR Clinical Research Network: Cancer
NIHR Health Technology Assessment (HTA) programme
University of Birmingham
University of Warwick
Last reviewed: 19 December 2018
CRUK internal database number: 8735
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
